Search Results - "Fukano, Reiji"

Refine Results
  1. 1

    Alectinib for relapsed or refractory anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: An open‐label phase II trial by Fukano, Reiji, Mori, Tetsuya, Sekimizu, Masahiro, Choi, Ilseung, Kada, Akiko, Saito, Akiko Moriya, Asada, Ryuta, Takeuchi, Kengo, Terauchi, Takashi, Tateishi, Ukihide, Horibe, Keizo, Nagai, Hirokazu

    Published in Cancer science (01-12-2020)
    “…Anaplastic lymphoma kinase (ALK) inhibition is expected to be a promising therapeutic strategy for ALK‐positive malignancies. We aimed to examine the efficacy…”
    Get full text
    Journal Article
  2. 2

    Necrotic Change of Tunica Media Plays a Key Role in the Development of Coronary Artery Lesions in Kawasaki Disease by Okada, Seigo, Sakai, Aiko, Ohnishi, Yuji, Yasudo, Hiroki, Motonaga, Takahiro, Fukano, Reiji, Waniishi, Takako, Sugiyama, Masaya, Hasegawa, Shunji

    Published in Circulation Journal (25-09-2024)
    “…Background: Alarmins resulting from cell death or oxidative stress are involved in the development of Kawasaki disease (KD) vasculitis. In a previous study, we…”
    Get full text
    Journal Article
  3. 3

    Sarcopenia and obesity in long-term survivors of childhood leukemia/lymphoma: a report from a single institution by Nakayama, Hideki, Noguchi, Maiko, Fukano, Reiji, Ueda, Tamaki, Taguchi, Shizu, Yoshimaru, Kenichi, Namie, Michiko, Shimokawa, Mototsugu, Okamura, Jun

    Published in Japanese journal of clinical oncology (01-07-2021)
    “…Background The incidence and background factors of sarcopenia and obesity in long-term survivors of childhood leukemia/lymphoma were not clear in Japan…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    The Effect of Vitamin K2 Supplementation on PIVKA-II Levels in Patients with Severe Motor and Intellectual Disabilities Undergoing Long-Term Tube Feeding by Ohmori, Hiromitsu, Kato, Akihiko, Shirai, Yuka, Fukano, Reiji, Nagae, Akiko, Yamasaki, Masami, Komenaka, Junko, Imamura, Eiji, Kumode, Masao, Miyachi, Takafumi

    Published in Nutrients (01-10-2023)
    “…Nutritional support is essential for patients with severe motor and intellectual disabilities (SMID) to ensure the smooth provision of medical care. These…”
    Get full text
    Journal Article
  8. 8

    Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease by Okada, Seigo, Yasudo, Hiroki, Ohnishi, Yuji, Matsuguma, Chie, Fukano, Reiji, Motonaga, Takahiro, Waniishi, Takako, Hasegawa, Shunji

    Published in Inflammation (01-02-2023)
    “…— Kawasaki disease (KD) is an acute, self-limiting, febrile systemic vasculitis of unknown cause associated with the development of coronary artery lesions…”
    Get full text
    Journal Article
  9. 9
  10. 10

    A single-center analysis of chronic graft-versus-host disease-free, relapse-free survival after alternative donor stem cell transplantation in children with hematological malignancies by Inagaki, Jiro, Fukano, Reiji, Noguchi, Maiko, Okamura, Jun

    Published in International journal of hematology (01-05-2017)
    “…We assessed the clinical outcomes of allogeneic hematopoietic stem cell transplantation (SCT) from alternative donors for pediatric patients with hematological…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Hematopoietic stem cell transplantation following unsuccessful salvage treatment for relapsed acute lymphoblastic leukemia in children by Inagaki, Jiro, Fukano, Reiji, Noguchi, Maiko, Kurauchi, Koichiro, Tanioka, Shinji, Okamura, Jun

    Published in Pediatric blood & cancer (01-04-2015)
    “…Background For children who experience a re‐induction failure or multiple recurrences following the first relapse of acute lymphoblastic leukemia (ALL), it is…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Phase II trial of CH5424802 (alectinib hydrochloride) for recurrent or refractory ALK-positive anaplastic large cell lymphoma: study protocol for a non-randomized non-controlled trial by Nagai, Hirokazu, Fukano, Reiji, Sekimizu, Masahiro, Kada, Akiko, M Saito, Akiko, Asada, Ryuta, Mori, Tetsuya

    Published in Nagoya journal of medical science (01-08-2017)
    “…Currently, a standard therapy has not been established for recurrent or refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. While…”
    Get full text
    Journal Article